Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients.

CONTEXT The risk of loco-regional recurrence in papillary thyroid cancer (PTC) patients ranges from 15-30%. However, the clinical significance of small-volume loco-regional recurrence detected by highly sensitive ultrasonography is unclear. OBJECTIVE Our objective was to describe the natural history of abnormal cervical lymph nodes (LN) diagnosed after initial treatment. DESIGN We conducted a retrospective cohort study. PATIENTS 166 PTC with patients who had at least one abnormal LN outside the thyroid be on ultrasound and selected for active surveillance were included. MAIN OUTCOME MEASURE LN growth during a period of active surveillance was the primary outcome. RESULTS Most patients had classical PTC (85%) and an intermediate risk of recurrence (77%). The median LN size at the start of the observation period was 1.3 cm (range, 0.5-2.7 cm) in largest diameter, with all nodes having at least one abnormal sonographic characteristic (70% of patients had LN with at least two abnormal features). In almost all patients, the LN were in the lateral neck, primarily in levels 3 (43%) and 4 (58%). After a median follow-up of 3.5 yr, only 20% (33 of 166) grew at least 3 mm, 9% (15 of 166) grew at least 5 mm, and 14% (23 of 166) resolved. None of the clinical or sonographic features were predictive of LN growth (positive predictive value range = 0.21-0.57). There were no local complications (nerve damage or local invasion) related to the abnormal nodes and no disease-related mortality. CONCLUSIONS Suspicious cervical LN in the lateral neck usually remain stable for long periods of time in properly selected PTC patients and can be safely followed with serial ultrasounds.

[1]  S. Mandel,et al.  Sonographic imaging of thyroid nodules and cervical lymph nodes. , 2008, Endocrinology and metabolism clinics of North America.

[2]  A. Miyauchi,et al.  An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients , 2009, World Journal of Surgery.

[3]  A. Oberg,et al.  Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long-term Outcome in 2444 Consecutively Treated Patients , 2002, World Journal of Surgery.

[4]  K. Schuff,et al.  Efficacy of Nodal Dissection for Treatment of Persistent/Recurrent Papillary Thyroid Cancer , 2008, The Laryngoscope.

[5]  B. Wolffenbuttel,et al.  Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma. , 2006, Clinical chemistry.

[6]  Tae Yong Kim,et al.  The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. , 2011, The Journal of clinical endocrinology and metabolism.

[7]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[8]  R. Kloos,et al.  Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer , 2001 .

[9]  R. Kloos,et al.  Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. , 2010, The Journal of clinical endocrinology and metabolism.

[10]  M. Graif,et al.  Cystic appearance of cervical lymph nodes is characteristic of metastatic papillary thyroid carcinoma , 2003, Journal of clinical ultrasound : JCU.

[11]  S. An,et al.  Radiologic and Pathologic Findings of Nonpalpable Thyroid Carcinomas Detected by Ultrasonography in a Medical Screening Center , 2008, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[12]  B. Caillou,et al.  Long‐term results and prognostic factors in patients with differentiated thyroid carcinoma , 1985, Cancer.

[13]  J. Shah,et al.  Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. , 2010, Thyroid : official journal of the American Thyroid Association.

[14]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[15]  L. Hann,et al.  Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. , 2011, Thyroid : official journal of the American Thyroid Association.